Broker Tips
Broker tips: AstraZeneca, Close Brothers, Shire
Jefferies upgraded AstraZeneca to 'buy' from 'hold' on Monday, lifting the price target to 5,600p from 5,075p as it said the pharmaceuticals giant is at a "turning point".
Shire still offers 50% upside, reckons Morgan Stanley
Analysts at Morgan Stanley took a fresh look at rare diseases specialist Shire on Monday, revisiting their bear case as the investment bank reiterated its 'overweight' rating on the group.
Jefferies ups AstraZeneca to 'buy', says it's at a 'turning point'
Jefferies upgraded AstraZeneca to 'buy' from 'hold' on Monday, lifting the price target to 5,600p from 5,075p as it said the pharmaceuticals giant is at a "turning point".
Monday broker round-up
Close Brothers Group plc: Berenberg downgrades to hold with a target price of 1,530p.
Berenberg downgrades Close Bros to 'hold', says valuation is now fair
Merchant bank Close Brothers was under the cosh on Monday as Berenberg cut the stock to 'hold' from 'buy', saying the valuation is now fair.